Immunotherapy for Guillain-Barré Syndrome
Practice Guideline, September 2003
Read Published ArticleThis practice parameter classifies the relevant evidence on immunotherapy to provide evidence-based recommendations for the management of GBS.
Reaffirmed on February 8, 2025.
Clinician Tools and Materials
Clinician Summary - Immunotherapy for Guillain-Barre Syndrome
Download a PDF summary of this guideline product好色先生al Materials
Other resources related to this guideline
Guideline Translations
Read guidelines in alternative languages
Patient Tools and Materials
Patient Summary - Immunotherapy for Guillain-Barre Syndrome
Read a summary of the key messages of this guideline product for patients and care partners.Patient Summary Translation
Translated in Spanish (Español)